Promisia Healthcare (NZSE:PHL) EBIT: NZ$17.51 Mil (TTM As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

NZSE:PHL Promisia Healthcare Ltd NZSE:PHL
33 GF Score
Price NZ$0.59
GF Value NZ$0.42
Valuation Significantly Overvalued
! 5 Warning Signs
View Full Analysis

What is Promisia Healthcare EBIT?

Promisia Healthcare NZSE:PHL 33 EBIT is NZ$17.51 Mil as of Mar. 2026. GuruFocus rates NZSE:PHL with a GF Score™ of 33/100 and a GF Value™ of NZ$0.42 (Significantly Overvalued). The stock has 5 warning signs investors should review.

Promisia Healthcare's earnings before interest and taxes (EBIT) for the six months ended in Mar. 2026 was NZ$15.38 Mil. Its earnings before interest and taxes (EBIT) for the trailing twelve months (TTM) ended in Mar. 2026 was NZ$17.51 Mil.

EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition. Promisia Healthcare's annualized ROC % for the quarter that ended in Mar. 2026 was 0.99%. Promisia Healthcare's annualized ROC (Joel Greenblatt) % for the quarter that ended in Mar. 2026 was 120.70%.

EBIT is also linked to Joel Greenblatt's definition of earnings yield. Promisia Healthcare's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Mar. 2026 was 10.86%.

Promisia Healthcare  (NZSE:PHL) EBIT Explanation

1. EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

Promisia Healthcare's annualized ROC % for the quarter that ended in Mar. 2026 is calculated as:

ROC % (Q: Mar. 2026 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (Q: Sep. 2025 ) + Invested Capital (Q: Mar. 2026 ))/ count )
=3.046 * ( 1 - 5.31% )/( (250.328 + 333.961)/ 2 )
=2.8842574/292.1445
=0.99 %

where

Invested Capital(Q: Sep. 2025 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=173.892 - 5.447 - ( 0.127 - max(0, 86.165 - 4.282+0.127))
=250.328

Invested Capital(Q: Mar. 2026 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=199.501 - 5.044 - ( 0.11 - max(0, 141.82 - 2.316+0.11))
=333.961

Note: The Operating Income data used here is two times the semi-annual (Mar. 2026) data.

2. Joel Greenblatt's definition of Return on Capital:

Promisia Healthcare's annualized ROC (Joel Greenblatt) % for the quarter that ended in Mar. 2026 is calculated as:

ROC (Joel Greenblatt) %(Q: Mar. 2026 )
=EBIT/Average of (Net fixed Assets + Net Working Capital)
=EBIT/Average of (Property, Plant and Equipment+Net Working Capital)
     Q: Sep. 2025  Q: Mar. 2026
=EBIT/( ( (Property, Plant and Equipment + Net Working Capital) + (Property, Plant and Equipment + Net Working Capital) )/ count )
=30.76/( ( (23.9 + max(-82.01, 0)) + (27.07 + max(-9.548, 0)) )/ 2 )
=30.76/( ( 23.9 + 27.07 )/ 2 )
=30.76/25.485
=120.70 %

where Working Capital is:

Working Capital(Q: Sep. 2025 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(2.554 + 0 + 1.601) - (5.447 + 0.419 + 80.299)
=-82.01

Working Capital(Q: Mar. 2026 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(1.504 + 0 + 0.702) - (5.044 + 6.71 + -2.8421709430404E-14)
=-9.548

When net working capital is negative, 0 is used.

Note: The EBIT data used here is two times the semi-annual (Mar. 2026) EBIT data.

3. It is also linked to Joel Greenblatt's definition of Earnings Yield:

Promisia Healthcare's Earnings Yield (Joel Greenblatt) % for today is calculated as:

Earnings Yield (Joel Greenblatt) %=EBIT (TTM)/Enterprise Value (Q: Mar. 2026 )
=17.505/161.230
=10.86 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Promisia Healthcare EBIT Related Terms

Promisia Healthcare EBIT Historical Data

* Premium members only.

The historical data trend for Promisia Healthcare's EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Promisia Healthcare EBIT Chart

Promisia Healthcare Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Mar22 Mar23 Mar24 Mar25 Mar26
EBIT
Get a 7-Day Free Trial Premium Member Only Premium Member Only 4.40 2.67 6.28 9.59 17.51

Promisia Healthcare Semi-Annual Data
Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Oct20 Sep21 Mar22 Sep22 Mar23 Sep23 Mar24 Sep24 Mar25 Sep25 Mar26
EBIT Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 5.07 6.88 2.71 2.13 15.38

NZSE:PHL vs HCA, THC, DVA: EBIT Comparison

For the Medical Care Facilities subindustry, Promisia Healthcare's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Promisia Healthcare EV-to-EBIT vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Promisia Healthcare's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Promisia Healthcare's EV-to-EBIT falls into.


NZSE:PHL
33GF Score
Promisia Healthcare Ltd NZSE:PHL
EBIT is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Promisia Healthcare EBIT Calculation

EBIT, sometimes also called Earnings Before Interest and Taxes, is a measure of a firm's profit that includes all expenses except interest and income tax expenses. It is the difference between operating revenues and operating expenses. When a firm does not have non-operating income, then Operating Income is sometimes used as a synonym for EBIT and operating profit.

EBIT for the trailing twelve months (TTM) ended in Mar. 2026 adds up the semi-annually data reported by the company within the most recent 12 months, which was NZ$17.51 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EBIT →
What does a EBIT of NZ$17.51 Mil mean?
Promisia Healthcare (NZSE:PHL) has a EBIT of NZ$17.51 Mil as of Mar. 2026. Earnings before interest and taxes is the difference between operating revenue and operating expenses. View historical data on Promisia Healthcare.
Is Promisia Healthcare's EBIT too high?
Promisia Healthcare's current EBIT is NZ$17.51 Mil. Overall, Promisia Healthcare has a GF Score™ of 33/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Promisia Healthcare's EBIT compare to HCA and THC?
Promisia Healthcare's EBIT of NZ$17.51 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBIT for a Healthcare Providers & Services company?
A good EBIT depends on the Healthcare Providers & Services industry context. However, EBIT should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBIT mean?
A high EBIT can signal that a stock is expensive relative to its fundamentals. Earnings before interest and taxes is the difference between operating revenue and operating expenses. View historical data on Promisia Healthcare. Promisia Healthcare's current EBIT is NZ$17.51 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Promisia Healthcare stock overvalued right now?
Based on GuruFocus' analysis, Promisia Healthcare (NZSE:PHL) is currently considered Significantly Overvalued. The stock's GF Value™ is NZ$0.42, compared to a current price of NZ$0.59 — trading 40.5% above its estimated fair value. The current EBIT is NZ$17.51 Mil. Promisia Healthcare's overall GF Score™ is 33/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBIT calculated?
EBIT is calculated from a company's financial statements. For Promisia Healthcare (NZSE:PHL), the current EBIT is NZ$17.51 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Promisia Healthcare (NZSE:PHL) Overvalued in 2026?

Based on GuruFocus' analysis, Promisia Healthcare stock appears to be overvalued. The current stock price of NZ$0.59 is trading 40.5% above its estimated GF Value™ of NZ$0.42. GuruFocus considers Promisia Healthcare to be Significantly Overvalued.

Key valuation signals for NZSE:PHL:

  • EBIT: NZ$17.51 Mil
  • GF Value™: NZ$0.42 vs. price of NZ$0.59 (40.5% above fair value)
  • GF Score™: 33/100 with 5 warning signs

No single metric tells the full story. See the NZSE:PHL stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Promisia Healthcare Business Description

Address 50 Customhouse Quay, Duncan Cotterill, Level 5, Wellington Central, Wellington, NTL, NZL, 6011
Promisia Healthcare Ltd is engaged in the provision of aged care in New Zealand. The company's services include Resthome Care, Hospital (Continuing) Care, Respite (Short Term) Care, Young Disabled Care, Dementia Care, and others. The Group operates in one operating segment: the provision of aged care in New Zealand.
33GF Score

Get the complete analysis for NZSE:PHL

EBIT is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NZ$0.59
Price
NZ$0.42
GF Value